Friday - April 17, 2026

CoreAge Rx Strengthens Patient Experience Through BBB Recognition, Positive Reviews, and High-Performance Delivery Model

Strong BBB presence, Trustpilot feedback, and consistent third-party recognition highlight a patient-focused approach to weight management care. CoreAge Rx, a LegitScript-certified telehealth weight management provider based in Wichita Falls, Texas, continues to build a strong reputation in the telehealth space … Continue reading

Phoenix Home Remodeling Listed Among Best Bathroom Remodeling Contractors in Phoenix by GeneralContractors.org

Phoenix bathroom remodel with freestanding tub and walk-in shower Phoenix Home Remodeling has been featured by GeneralContractors.org in its list of Best Bathroom Remodeling Contractors in Phoenix, Arizona, highlighting the company’s work in bathroom renovation projects across the greater Phoenix … Continue reading

Renal Cell Carcinoma Treatment Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Renal Cell Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Renal Cell Carcinoma pipeline landscape. It covers the Renal Cell Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Congenital Hyperinsulinism Clinical Trial Pipeline Expands as 4+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Congenital Hyperinsulinism Pipeline Insight 2026” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in the Congenital Hyperinsulinism pipeline landscape. It covers the Congenital Hyperinsulinism pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

End-stage Renal Disease Clinical Trial Pipeline Accelerates as 4+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “End-stage Renal Disease Pipeline Insight 2026” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in the End-stage Renal Disease pipeline landscape. It covers the End-stage Renal Disease pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Spinal Cord Injury Clinical Trial Pipeline Gains Momentum: 25+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Spinal Cord Injury Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Spinal Cord Injury pipeline landscape. It covers the Spinal Cord Injury pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Primary Biliary Cholangitis Pipeline Set for Major Breakthroughs by 2026 with 25+ Therapies and Strong Clinical Momentum from GlaxoSmithKline, Novartis, and CymaBay Therapeutics | DelveInsight

Primary Biliary Cholangitis Pipeline Primary Biliary Cholangitis Companies such as Genfit, Zydus Discovery, Ohara Pharmaceutical, Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Novartis, CymaBay Therapeutics, Calliditas Therapeutics, Hepagene, Calliditas Therapeutics, Dr Falk Pharma, Mirum Pharmaceuticals, GlaxoSmithKline, and others DelveInsight’s, “Primary … Continue reading